cached image

Ali Salahpour

Affiliations: 
Pharmacology and Toxicology University of Toronto, Toronto, ON, Canada 
Website:
http://www.pharmtox.utoronto.ca/faculty/directory/salapour.htm
Google:
"Ali Salahpour"
Bio:

http://www.pharmtox.utoronto.ca/Assets/Pharmtox+Digital+Assets/Graduate/Almanacs/July-August-2009.pdf

Mean distance: 16.3 (cluster 11)
 
SNBCP
Cross-listing: Chemistry Tree

Parents

Sign in to add mentor
Michel Bouvier grad student 1996-2002 Université de Montréal
 (Etude de la dimerisaton du recepteur beta2-adrenergique.)
Marc Caron post-doc 2002-2009 Duke
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Vecchio LM, Sullivan P, Dunn AR, et al. (2021) Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo. Journal of Neurochemistry
Mielnik CA, Sugamori KS, Finlay DB, et al. (2020) A novel allosteric modulator of the cannabinoid CB receptor ameliorates hyperdopaminergia endophenotypes in rodent models. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Mielnik CA, Binko MA, Chen Y, et al. (2020) Consequences of NMDA receptor deficiency can be rescued in the adult brain. Molecular Psychiatry
Intson K, van Eede MC, Islam R, et al. (2019) Progressive neuroanatomical changes caused by Grin1 loss-of-function mutation. Neurobiology of Disease. 104527
Chen Y, Milenkovic M, Horsfall W, et al. (2018) Restoring striatal WAVE-1 improves maze exploration performance of GluN1 knockdown mice. Plos One. 13: e0199341
Lam VM, Mielnik CA, Baimel C, et al. (2018) Behavioral Effects of a Potential Novel TAAR1 Antagonist. Frontiers in Pharmacology. 9: 953
Islam R, Trépanier MO, Milenkovic M, et al. (2017) Vulnerability to omega-3 deprivation in a mouse model of NMDA receptor hypofunction. Npj Schizophrenia. 3: 12
Beerepoot P, Nazari R, Salahpour A. (2016) Pharmacological chaperone approaches for rescuing GPCR mutants: Current state, challenges, and screening strategies. Pharmacological Research
Beerepoot P, Lam VM, Salahpour A. (2016) Pharmacological Chaperones of the Dopamine Transporter Rescue Dopamine Transporter Deficiency Syndrome Mutations in Heterologous Cells. The Journal of Biological Chemistry
Lohr KM, Masoud ST, Salahpour A, et al. (2016) Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease. The European Journal of Neuroscience
See more...